RAD51 135G→C modifies breast cancer risk among BRCA2 mutation carriers: Results from a combined analysis of 19 studies

American Journal of Human Genetics

Volumn 81, Issue 6, 2007, Pages 1186-1200

  Antoniou, Antonis C ^a,b   Sinilnikova, Olga M ^d,e   Simard, Jacques ^g   Léoné, Mélanie ^d   Dumont, Martine ^g   Neuhausen, Susan L ^h   Struewing, Jeffery P ^i,j   Stoppa Lyonnet, Dominique ^k   Barjhoux, Laure ^d,e   Hughes, David J ^l   Coupier, Isabelle ^k,ba   Belotti, Muriel ^k   Lasset, Christine ^e,f   Bonadona, Valérie ^e,f   Bignon, Yves Jean ⁿ   Rebbeck, Timothy R ^o,p   Wagner, Theresa ^s   Lynch, Henry T ^s,t   Domchek, Susan M ^p,q   Nathanson, Katherine L ^p,q   Garber, Judy E ^u   Weitzel, Jeffrey ^v   Narod, Steven A ^w   Tomlinson, Gail ^y   Olopade, Olufunmilayo I ^z   Godwin, Andrew ^r   Isaacs, Claudine ^aa   Jakubowska, Anna ^ab   Lubinski, Jan ^ab   Gronwald, Jacek ^ab   Górski, Bohdan ^ab   Byrski, Tomasz ^ab   Huzarski, Tomasz ^ab   Peock, Susan ^b,bo   Cook, Margaret ^b,bo   Baynes, Caroline ^c   Murray, Alexandra ^ac,bs   Rogers, Mark ^ac,bs   Daly, Peter A ^m   Dorkins, Huw ^ad,bx   Schmutzler, Rita K ^ae   Versmold, Beatrix ^ae   Engel, Christoph ^af   Meindl, Alfons ^ag   Arnold, Norbert ^ah   Niederacher, Dieter ^ai   Deissler, Helmut ^aj   Spurdle, Amanda B ^ak   Chen, Xiaoqing ^ak   Waddell, Nicola ^ak   Cloonan, Nicole ^al   Kirchhoff, Tomas ^am   Offit, Kenneth ^am   Friedman, Eitan ^an   Kaufmann, Bella ^an   Laitman, Yael ^an   Galore, Gilli ^an   Rennert, Gad ^ao   Lejbkowicz, Flavio ^ao   Raskin, Leon ^ao   Andrulis, Irene L ^x,y   Ilyushik, Eduard ^x   Ozcelik, Hilmi ^x   Devilee, Peter ^m,ap   Vreeswijk, Maaike P G ^ap   Greene, Mark H ⁱ   Prindiville, Sheila A ^i,j   Osorio, Ana ^aq   Benítez, Javier ^aq   Zikan, Michal ^ar   Szabo, Csilla I ^as   Kilpivaara, Outi ^at   Nevanlinna, Heli ^at   Hamann, Ute ^au   Durocher, Francine ^g   Arason, Adalgeir ^av   Couch, Fergus J ^as   Easton, Douglas F ^b   Chenevix Trench, Georgia ^aj   Chompret, Agnès ^aw   Bressac de Paillerets, Brigitte ^aw   Byrde, Véronique ^aw   Capoulade, Corinne ^aw   Lenoir, Gilbert ^aw   Uhrhammer, Nancy ⁿ   Gauthier Villars, Marion ^k   De Pauw, Antoine ^k   Sinilnikova, Olga ^d   Giraud, Sophie ^d   Hardouin, Agnès ^ax   Berthet, Pascaline ^ax   Sobol, Hagay ^ay   Bourdon, Violaine ^ay   Eisinger, François ^ay   Coulet, Florence ^az   Colas, Chrystelle ^az   Soubrier, Florent ^az   Peyrat, Jean Philippe ^bb   Fournier, Joëlle ^bb   Vennin, Philippe ^bb   Adenis, Claude ^bb   Nogues, Catherine ^bc   Lidereau, Rosette ^bc   Muller, Danièle ^bd   Fricker, Jean Pierre ^bd   Longy, Michel ^be   Toulas, Christine ^bf   Guimbaud, Rosine ^bf   Gladieff, Laurence ^bf   Feillel, Viviane ^bf   Leroux, Dominique ^bg   Dreyfus, Hélène ^bg   Rebischung, Christine ^bg   Olivier Faivre, Laurence ^bh   Prieur, Fabienne ^bi   Frénay, Marc ^bj   Mazoyer, Sylvie ^bk   Yannoukakos, Drakoulis ^bl   Engel, Cassandra ^bm   Haites, Neva ^bn   Gregory, Helen ^bn   Morrison, Patrick ^bo   Cole, Trevor ^bp   McKeown, Carole ^bp   Donaldson, Alan ^bq   Paterson, Joan ^br   Gray, Jonathon ^bs   Daly, Peter ^m   Barton, David ^bt   Porteous, Mary ^bu   Steel, Michael ^bu   Brewer, Carole ^bv   Rankin, Julia ^bv   Davidson, Rosemarie ^bw   Murday, Victoria ^bw   Izatt, Louise ^bx   Pichert, Gabriella ^by   Trembath, Richard ^bz   Bishop, Tim ^ca   Chu, Carol ^ca   Ellis, Ian ^cb   Evans, Gareth ^cc   Lalloo, Fiona ^cc   Shenton, Andrew ^cc   Mackay, James ^cd   Robinson, Anne ^cd   Ritchie, Susan ^ce   Douglas, Fiona ^cf   Burn, John ^cf   Side, Lucy ^cg   Durell, Sarah ^cg   Eeles, Ros ^ch   Cook, Jackie ^ci   Quarrell, Oliver ^ci   Hodgson, Shirley ^cj   Eccles, Diana ^ck   Lucassen, Anneke ^ck   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d HOSPICES CIVILS DE LYON   (France)

^e UNIVERSITÉ LYON 1   (France)

^f CENTRE LÉON BÉRARD   (France)

^g LAVAL UNIVERSITY   (Canada)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ Laboratory of Molecular Biology   (United States)

^j NATIONAL CANCER INSTITUTE   (United States)

^k INSTITUT CURIE   (France)

^l TRINITY COLLEGE DUBLIN   (Ireland)

^m ST JAMES S HOSPITAL   (Ireland)

ⁿ CENTRE JEAN PERRIN   (France)

^o UNIVERSITY OF PENNSYLVANIA   (United States)

^p Abramson Cancer Center ^*  (United States)

^q UNIVERSITY OF PENNSYLVANIA   (United States)

^r UNIVERSITY OF VIENNA   (Austria)

^s CREIGHTON UNIVERSITY   (United States)

^t DANA FARBER CANCER INSTITUTE   (United States)

^u CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^v WOMEN S COLLEGE HOSPITAL   (Canada)

^w MOUNT SINAI HOSPITAL   (Canada)

^x CANCER CARE ONTARIO   (Canada)

^y UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^z UNIVERSITY OF CHICAGO   (United States)

^aa GEORGETOWN UNIVERSITY   (United States)

^ab POMERANIAN MEDICAL UNIVERSITY   (Poland)

^ac UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^ad NORTHWICK PARK HOSPITAL   (United Kingdom)

^ae UNIVERSITY OF COLOGNE   (Germany)

^af UNIVERSITY OF LEIPZIG   (Germany)

^ag TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^ah UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^ai HEINRICH HEINE UNIVERSITY   (Germany)

^aj UNIVERSITY OF ULM   (Germany)

^ak QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^al UNIVERSITY OF QUEENSLAND   (Australia)

^am MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^an GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^ao CARMEL MEDICAL CENTER   (Israel)

^ap LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^aq Centro Nacional de Investigaciones Oncológicas   (Spain)

^ar CHARLES UNIVERSITY   (Czech Republic)

^as Mayo Clinic   (United States)

^at HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^au GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^av LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^aw INSTITUT GUSTAVE ROUSSY   (France)

^ax CENTRE FRANÇOIS BACLESSE   (France)

^ay INSTITUT PAOLI CALMETTES   (France)

^az PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^ba HÔPITAL ARNAUD DE VILLENEUVE   (France)

^bb CENTRE OSCAR LAMBRET   (France)

^bc CENTRE RENÉ HUGUENIN   (France)

^bd CENTRE PAUL STRAUSS   (France)

^be INSTITUT BERGONIÉ   (France)

^bf INSTITUT CLAUDIUS REGAUD   (France)

^bg GRENOBLE UNIVERSITY HOSPITAL   (France)

^bh DIJON UNIVERSITY HOSPITAL   (France)

^bi UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^bj CENTRE ANTOINE LACASSAGNE   (France)

^bk CNRS   (France)

^bl INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^bm Centre Antoine Lacassagne ^*  (United Kingdom)

^bn North of Scotland Regional Genetics Service   (United Kingdom)

^bo Northern Ireland Regional Genetics Service   (United Kingdom)

^bp West Midlands Regional Clinical Genetics Service   (United Kingdom)

^bq South West Regional Genetics Service   (United Kingdom)

^br East Anglian Regional Genetics Service   (United Kingdom)

^bs Medical Genetics Services for Wales   (United Kingdom)

^bt National Centre for Medical Genetics   (Ireland)

^bu Ardmillan House   (United Kingdom)

^bv Peninsula Clinical Genetics Service   (United Kingdom)

^bw West of Scotland Regional Genetics Service   (United Kingdom)

^bx GUY S HOSPITAL   (United Kingdom)

^by North Thames   (United Kingdom)

^bz Leicestershire Clinical Genetics Service   (United Kingdom)

^ca Yorkshire Regional Genetics Service   (United Kingdom)

^cb Merseyside and Cheshire Clinical Genetics Service   (United Kingdom)

^cc Manchester Regional Genetics Service   (United Kingdom)

^cd Dept Postgrad Gen Practice Educ   (United Kingdom)

^ce NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^cf Northern Clinical Genetics Service   (United Kingdom)

^cg Oxford Regional Genetics Service   (United Kingdom)

^ch Royal Marsden Hospital   (United Kingdom)

^ci Sheffield Clinical Genetics Service   (United Kingdom)

^cj SouthWest Thames Regional Genetics Service   (United Kingdom)

^ck Wessex Clinical Genetics Service   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN; CYTOSINE; GUANINE; RAD51 PROTEIN; BRCA1 PROTEIN; PRIMER DNA; RAD51 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BREAST CANCER; CANCER RISK; CONFIDENCE INTERVAL; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAZARD ASSESSMENT; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; ADOLESCENT; ALTERNATIVE RNA SPLICING; BREAST TUMOR; CLINICAL TRIAL; DNA REPAIR; FAMILY; GENETICS; HETEROZYGOTE; HOMOZYGOTE; MIDDLE AGED; MULTICENTER STUDY; MUTATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; ALTERNATIVE SPLICING; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA PRIMERS; DNA REPAIR; FAMILY; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RAD51 RECOMBINASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VARIATION (GENETICS);

EID: 36749002743     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/522611     Document Type: Article

References (59)

1. Breast Cancer Information Core, http://research.nhgri.nih.gov/projects/ bic/
2. ESE Finder, http://rulai.cshl.edu/tools/ESE/
3. GenBank, http://www.ncbi.nlm.nih.gov/Genbank/ (for RAD51 transcripts [accession numbers NM_002875 and AK131299])
4. International HapMap Project, http://www.hapmap.org/
5. Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/ Omim/ (for BRCA1, BRCA2, G6PD, GAPDH, ACTB, and CASC5)
6. RNA and DNA Folding Applications, http://www.bioinfo.rpi.edu/ applications/mfold/
7. SpliceSiteFinder, http://violin.genet.sickkids.on.ca/~ali/ splicesitefinder.html
8. Splice Site Prediction, http://www.fruitfly.org/seq_tools/splice.html
9. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117-1130
10. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE, Breast Cancer Linkage Consortium (1994) Risks of cancer in BRCA1-mutation carriers. Lancet 343:692-695
11. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT,Weber B, Lenoir G, Chang-Claude J, et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62:676-689
12. Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401-1408
13. Simchoni S, Friedman E, Kaufman B, Gershoni-Baruch R, Orr-Urtreger A, Kedar-Barnes I, Shiri-Sverdlov R, Dagan E, Tsabari S, Shohat M, et al (2006) Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population. Proc Natl Acad Sci USA 103:3770-3774
14. Pellegrini L, Venkitaraman A (2004) Emerging functions of BRCA2 in DNA recombination. Trends Biochem Sci 29:310-316
15. Karran P (2000) DNA double strand break repair in mammalian cells. Curr Opin Genet Dev 10:144-150
16. Scully R, Chen J, Plug A, Xiao Y,Weaver D, Feunteun J, Ashley T, Livingston DM (1997) Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88:265-275
17. Wong AK, Pero R, Ormonde PA, Tavtigian SV, Bartel PL (1997) RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2. J Biol Chem 272:31941-31944
18. -/- background. Mol Cell Biol 19:8686-8693
19. Wang WW, Spurdle AB, Kolachana P, Bove B, Modan B, Ebbers SM, Suthers G, Tucker MA, Kaufman DJ, Doody MM, et al (2001) A single nucleotide polymorphism in the 5′ untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. Cancer Epidemiol Biomarkers Prev 10:955-960
20. Levy-Lahad E, Lahad A, Eisenberg S, Dagan E, Paperna T, Kasinetz L, Catane R, Kaufman B, Beller U, Renbaum P, et al (2001) A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers. Proc Natl Acad Sci USA 98:3232-3236
21. Kadouri L, Kote-Jarai Z, Hubert A, Durocher F, Abeliovich D, Glaser B, Hamburger T, Eeles RA, Peretz T (2004) A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers. Br J Cancer 90:2002-2005
22. Jakubowska A, Narod SA, Goldgar DE, Mierzejewski M, Masojc B, Nej K, Huzarska J, Byrski T, Gorski B, Lubinski J (2003) Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland. Cancer Epidemiol Biomarkers Prev 12:457-459
23. Jakubowska A, Gronwald J, Menkiszak J, Gorski B, Huzarski T, Byrski T, Edler L, Lubinski J, Scott RJ, Hamann U (2007) The RAD51 135 G>C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev 16:270-275
24. Chenevix-Trench G, Milne RL, Antoniou AC, Couch FJ, Easton DF, Goldgar DE (2007) An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Res 9:104
25. Goldgar DE, Easton DF, Deffenbaugh AM, Monteiro AN, Tavtigian SV, Couch FJ (2004) Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. Am J Hum Genet 75:535-544
26. Chenevix-Trench G, Healey S, Lakhani S, Waring P, Cummings M, Brinkworth R, Deffenbaugh AM, Burbidge LA, Pruss D, Judkins T, et al (2006) Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance. Cancer Res 66:2019-2027
27. Liu HX, Cartegni L, Zhang MQ, Krainer AR (2001) A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat Genet 27:55-58
28. Perrin-Vidoz L, Sinilnikova OM, Stoppa-Lyonnet D, Lenoir GM, Mazoyer S (2002) The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons. Hum Mol Genet 11:2805-2814
29. Ware MD, DeSilva D, Sinilnikova OM, Stoppa-Lyonnet D, Tavtigian SV, Mazoyer S (2006) Does nonsense-mediated mRNA decay explain the ovarian cancer cluster region of the BRCA2 gene? Oncogene 25:323-328
30. Mikaelsdottir EK, Valgeirsdottir S, Eyfjord JE, Rafnar T (2004) The Icelandic founder mutation BRCA2 999del5: analysis of expression. Breast Cancer Res 6:R284-R290
31. Buisson M, Anczukow O, Zetoune AB, Ware MD, Mazoyer S (2006) The 185delAG mutation (c.68_69delAG) in the BRCA1 gene triggers translation reinitiation at a downstream AUG codon. Hum Mutat 27:1024-1029
32. Bonadona V, Dussart-Moser S, Voirin N, Sinilnikova OM, Mignotte H, Mathevet P, Bremond A, Treilleux I, Martin A, Romestaing P, et al (2007) Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review. Breast Cancer Res Treat 101:233-245
33. Andrieu N, Goldgar D, Easton D, Rookus MA, Brohet R, Antoniou AC, Peock S, Evans DG, Eccles D, Douglas F, et al (2006) Pregnancies, breastfeeding and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). J Natl Cancer Inst 98:535-544
34. Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, et al (2002) Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346:1616-1622
35. Antoniou AC, Goldgar DE, Andrieu N, Chang-Claude J, Brohet R, Rookus MA, Easton DF (2005) A weighted cohort approach for analysing factors modifying disease risks in carriers of high-risk susceptibility genes. Genet Epidemiol 29:1-11
36. Kadouri L, Kote-Jarai Z, Easton DF, Hubert A, Hamoudi R, Glaser B, Abeliovich D, Peretz T, Eeles RA (2004) Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCA1 carriers. Int J Cancer 108:399-403
37. Antoniou AC, Pharoah PD, McMullan G, Day NE, Ponder BA, Easton D (2001) Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol 21:1-18
38. Lange K, Weeks D, Boehnke M (1988) Programs for pedigree analysis: MENDEL, FISHER, and dGENE. Genet Epidemiol 5:471-472
39. Anglian Breast Cancer Study Group (2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Br J Cancer 83:1301-1308
40. Cox DR, Oakes D (1984) Analysis of survival data. Chapman and Hall, London
41. Lalloo F, Varley J, Ellis D, Moran A, O'Dair L, Pharoah P, Evans DG (2003) Prediction of pathogenic mutations in patients with early-onset breast cancer by family history. Lancet 361:1101-1102
42. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, Evans C, Deacon J, Stratton MR (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91:943-949
43. Antoniou AC, Pharoah PP, Smith P, Easton DF (2004) The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer 91:1580-1590
44. Kadouri L, Easton DF, Edwards S, Hubert A, Kote-Jarai Z, Glaser B, Durocher F, Abeliovich D, Peretz T, Eeles RA (2001) CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers. Br J Cancer 85:36-40
45. Huber PJ (1967) The behavior of maximum likelihood estimates under non-standard conditions. Proc Fifth Berkley Symp Math Stat Probab 1:221-233
46. Boos DD (1992) On generalised score tests. Am Stat 46:327-333
47. Luu-The V, Paquet N, Calvo E, Cumps J (2005) Improved real-time RT-PCR method for high-throughput measurements using second derivative calculation and double correction. Biotechniques 38:287-293
48. Kuschel B, Auranen A, McBride S, Novik KL, Antoniou A, Lipscombe JM, Day NE, Easton DF, Ponder BA, Pharoah PD, et al (2002) Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 11:1399-1407
49. Webb PM, Hopper JL, Newman B, Chen X, Kelemen L, Giles GG, Southey MC, Chenevix-Trench G, Spurdle AB (2005) Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer. Cancer Epidemiol Biomarkers Prev 14:319-323
50. Kramer JL, Velazquez IA, Chen BE, Rosenberg PS, Struewing JP, Greene MH (2005) Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers. J Clin Oncol 23:8629-8635
51. Obuse C, Iwasaki O, Kiyomitsu T, Goshima G, Toyoda Y, Yanagida M (2004) A conserved Mis12 centromere complex is linked to heterochromatic HP1 and outer kinetochore protein Zwint-1. Nat Cell Biol 6:1135-1141
52. Kuefer MU, Chinwalla V, Zeleznik L, Behm FG, Naeve CW, Rakestraw KM, Mukatira ST, Raimondi SC, Morris SW (2003) Characterization of the MLL partner gene AF15q14 involved in t(11;15)(q23;q14). Oncogene 22:1418-1424
53. Hayette S, Tigaud I, Vanier A, Martel S, Corbo L, Charrin C, Beillard E, Deleage G, Magaud JP, Rimokh R (2000) AF15q14, a novel partner gene fused to the MLL gene in an acute myeloid leukaemia with a t(11;15)(q23;q14). Oncogene 19:4446-4450
54. Chinwalla V, Chien A, Odero M, Neilly MB, Zeleznik L, Rowley JD (2003) A t(11;15) fuses MLL to two different genes, AF15q14 and a novel gene MPFYVE on chromosome 15. Oncogene 22:1400-1410
55. Shivji MK, Davies OR, Savill JM, Bates DL, Pellegrini L, Venkitaraman AR (2006) A region of human BRCA2 containing multiple BRC repeats promotes RAD51-mediated strand exchange. Nucleic Acids Res 34:4000-4011
56. Hasselbach L, Haase S, Fischer D, Kolberg HC, Sturzbecher HW (2005) Characterisation of the promoter region of the human DNA-repair gene Rad51. Eur J Gynaecol Oncol 26:589-598
57. Zuker M (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31:3406-3415
58. Davuluri RV, Suzuki Y, Sugano S, Zhang MQ (2000) CART classification of human 5′ UTR sequences. Genome Res 10:1807-1816
59. Hughes TA (2006) Regulation of gene expression by alternative untranslated regions. Trends Genet 22:119-122